Vai al contenuto principale

Dott.ssa Martina Ferrante

Attività di ricerca

Non invasive diagnostic tools for minimal residual disease monitoring in lymphoproliferative disorders

 

  1. Della Starza et al. IMMUNOGLOBULIN KAPPA DELETING ELEMENT REARRANGEMENTS ARE CANDIDATE TARGETS FOR MINIMAL RESIDUAL DISEASE EVALUATION IN MANTLE CELL LYMPHOMA. Hematol Oncol. 2020 Aug 20. Online ahead of print.
  2. Drandi et al. DROPLET DIGITAL PCR QUANTIFICATION OF MANTLE CELL LYMPHOMA FOLLOW-UP SAMPLES FROM FOUR PROSPECTIVE TRIALS OF THE EUROPEAN MCL NETWORK. Hemasphere. 2020 Apr 3;4(2):e347.
  3. Lo Schirico et al. DROPLET DIGITAL PCR ASSAY FOR MYD88L265P: CLINICAL APPLICATIONS IN WALDENSTRÖM MACROGLOBULINEMIA. Hemasphere. 2020 Jan 3;4(1):e324.
  4. Grimaldi et al. MINIMAL RESIDUAL DISEASE IN INDOLENT LYMPHOMAS: A CRITICAL ASSESSMENT. Curr. Treat. Options Oncol. 19, 71 (2018).
  5. Drandi et al. HIGHLY SENSITIVE MYD88L265P MUTATION DETECTION BY DROPLET DIGITAL POLYMERASE CHAIN REACTION IN WALDENSTRÖM MACROGLOBULINEMIA. Haematologica. 2018 Jun;103(6):1029-1037.
  6. Simiele et al. UPLC-MS/MS METHOD FOR THE SIMULTANEOUS QUANTIFICATION OF THREE NEW ANTIRETROVIRAL DRUGS, DOLUTEGRAVIR, ELVITEGRAVIR AND RILPIVIRINE, AND OTHER THIRTEEN ANTIRETROVIRAL AGENTS PLUS COBICISTAT AND RITONAVIR BOOSTERS IN HUMAN PLASMA. J. Pharm. Biomed. Anal. 138, 223–230 (2017).

 

  1. Varettoni et al. Characterization of B-cell and Plasma Cell Compartment by Eight-Color Multiparameter Flow Cytometry in Patients with Waldenstrom Macroglobulinemia Prospectively Enrolled in the Fondazione Italiana Linfomi (FIL) BIO-WM Trial; ASH (AMERICAN SOCIETY OF HEMATOLOGY) 2020.
  2. Ferrero et al. DROPLET DIGITAL PCR FOR NON-INVASIVE MUTATIONAL SCREENING IN WALDENSTRÖM MACROGLOBULINEMIA AND IGM-MGUS: FIRST RESULTS OF THE FONDAZIONE ITALIANA LINFOMI (FIL) BIO-WM TRIAL; EHA25 VIRTUAL (European Hematology Association) 
  3. Ferrante et al; DROPLET DIGITAL PCR FOR NON-INVASIVE MUTATIONAL SCREENING IN WALDENSTRÖM MACROGLOBULINEMIA AND IGM-MGUS: FIRST RESULTS OF THE FONDAZIONE ITALIANA LINFOMI (FIL) BIO-WM TRIAL; XVI CONGRESSO NAZIONALE SIES (Società Italiana di Ematologia Sperimentale) 2020.
  4. Ferrante et al; DDPCR AND ASQPCR COMPARISON FOR MYD88(L265P) IDENTIFICANTION IN CD19+ SELECTED AND UNSELECTED SAMPLES FROM WM AND IGM-MGUS PATIENTS; 47° Congresso Nazionale SIE (Società Italiana di Ematologia) 2019.
  5. Ferrante et al; NON INVASIVE DIAGNOSTICS OF MYD88(L265P) IN WALDENSTRÖM MACROGLOBULINEMIA AND IGM-MGUS PATIENTS; UNDER40 in Hematology 2018

  1. 8th ESLHO Symposium, Ghent, Belgium, 7-9 Nov 2019. Oral presentation: “Comparison of bone marrow, peripheral blood and cell-free DNA for MYD88L265P mutation detection and minimal residual disease monitoring in Waldenström Macroglomulinemia”
  2. 47° Congresso Nazionale SIE (Italian Society of Hematology), Roma, Italy, 8-10 Oct 2019. Poster presentation: “ddPCR and AS-PCR comparison for MYD88(L265P) identificantion in CD19+ selected and unselected samples from WM and IgM-MGUS patients”
  3. UNDER40 in Hematology, Roma, Italy, 15-16 Nov 2018. Oral presentation: “Non invasive diagnostics of MYD88(L265P) in Waldenström Macroglobulinemia and IgM-MGUS patients”

 

  1. Convegno “NEXT GENERATION SEQUENCING. Dal laboratorio alla pratica clinica: un
    percorso ad ostacoli ?” (Milano, 03/04/2019)
  2. ADE Immunoterapia dei Tumori (Torino, 15/03/2019 -05/04/2019)
  3. QUALITY CONTROL ROUND (QC19) - FIL MRD Network (Milano, 13/05/2019)
  4. Percorso di formazione “La valorizzazione dei risultati di ricerca - Corso sulla proprietà intellettuale" (Torino, 06/06/2019)
  5. WEBINAR "Digital Droplet PCR for the Detection of Extracellular Vesicle (EV)-Derived Biomarkers" (13/09/2019)
  6. Workshop Advanced Analytical Technologies for Life Sciences INRIM (Torino, 02/10/2019)
  7. Commissione Studi Biologici FIL (Fondazione Italiana Linfomi) (Milano, 21/10/2019)
  8. WEBINAR "Digital PCR Method Development for Accurate Quantification of Copy Number Variations" (27/02/2020)
  9. WEBINAR "Illumina Virtual Benchtop Day per l’Italia" (20-21/04/2020)
  10. WEBINAR "L'impatto del Covid19 sule professioni sanitarie/elevate competenze" (04/06/2020)
  11. WWBINAR "SARS COV 2, Teachings for the future from the health emergency" (12/06/2020)
  12. WEBINAR SERIES AT DEPARTMENT OF MOLECULAR BIOTECHNOLOGY AND HEALTHY SCIENCES -"Immune activation models the tissue stroma: lesson from conventional and germ-free animal models" PROF. LUCA VANNUCCI (15/07/2020)
  13. WEBINAR "Biobanking and the Future of Precision Medicine" (01/09/2020)

 

 

 

 

 

Ultimo aggiornamento: 26/05/2022 16:17
Non cliccare qui!